RE: RE: LFB = AcquirerHowever one thing I am sure LFB would not spend that kind of money if there is no commercial value for Shigamabs.
Pure lobster thinking. Your nick is well chosen. Ask Eli Lilly if they tought they would make money when they gave 87 M upfront for Dicurotide. Dumbo knows about that. It is one of his many failed biotech gambles. There is many other exemples like that. Remember that Shigamabs has never been tested on human for efficacy. Nothing is sure there, as it was the case for 4601.